Chemokines and their receptors: drug targets in immunity and inflammation.

The chemokine system coordinates leukocyte migration in immunity and inflammation and is implicated in the pathogenesis of many human diseases. Although several successful strategies have been identified to develop drugs targeting chemokines and their receptors, this has not yet resulted in many new therapeutics. This is likely due to a complexity of the chemokine system, which was not initially appreciated, that is characterized by redundancy, pleiotropy, and differences among species. Nevertheless, our understanding of chemokine biology is continuing to grow and several promising drugs are currently being tested in late-stage clinical trials. In this review, we examine the role of chemokines in health and diseases and discuss strategies to target the chemokine system.

[1]  Jian Li,et al.  Anti-IL-13 monoclonal antibody inhibits airway hyperresponsiveness, inflammation and airway remodeling. , 2004, Cytokine.

[2]  W. Hancock,et al.  Chemokines and their receptors as markers of allograft rejection and targets for immunosuppression. , 2003, Current opinion in immunology.

[3]  Murphy Pm.  Neutrophil receptors for interleukin-8 and related CXC chemokines. , 1997 .

[4]  Klemens Budde,et al.  CC chemokine receptor 5 and renal-transplant survival , 2001, The Lancet.

[5]  Andrew L Kung,et al.  A small-molecule antagonist of CXCR4 inhibits intracranial growth of primary brain tumors , 2003, Proceedings of the National Academy of Sciences of the United States of America.

[6]  R. Proia,et al.  Lymphocyte egress from thymus and peripheral lymphoid organs is dependent on S1P receptor 1 , 2004, Nature.

[7]  W. Metz,et al.  Unraveling the chemistry of chemokine receptor ligands. , 2003, Chemical reviews.

[8]  Timothy N. C. Wells,et al.  Glycosaminoglycan binding and oligomerization are essential for the in vivo activity of certain chemokines , 2003, Proceedings of the National Academy of Sciences of the United States of America.

[9]  D. Friend,et al.  The murine CCR3 receptor regulates both the role of eosinophils and mast cells in allergen-induced airway inflammation and hyperresponsiveness , 2002, Proceedings of the National Academy of Sciences of the United States of America.

[10]  G. Otto,et al.  CC chemokine receptor 5Δ32 polymorphism—a risk factor for ischemic‐type biliary lesions following orthotopic liver transplantation , 2004 .

[11]  C. Garlanda,et al.  Defective dendritic cell migration and activation of adaptive immunity in PI3Kγ‐deficient mice , 2004 .

[12]  Silvano Sozzani,et al.  Central role for G protein-coupled phosphoinositide 3-kinase γ in inflammation , 2000 .

[13]  Steven M. Wolinsky,et al.  Relative resistance to HIV–1 infection of CD4 lymphocytes from persons who remain uninfected despite multiple high–risk sexual exposures , 1996, Nature Medicine.

[14]  Stuart B. Goodman,et al.  Lymphocyte Cc Chemokine Receptor 9 and Epithelial Thymus-Expressed Chemokine (Teck) Expression Distinguish the Small Intestinal Immune Compartment , 2000, The Journal of experimental medicine.

[15]  Antonio Lanzavecchia,et al.  T cell costimulation by chemokine receptors , 2005, Nature Immunology.

[16]  A. Tager,et al.  Signal Transducer and Activator of Transcription 6 Controls Chemokine Production and T Helper Cell Type 2 Cell Trafficking in Allergic Pulmonary Inflammation , 2001, The Journal of experimental medicine.

[17]  A. Tager,et al.  Leukotriene B4 and BLT1 control cytotoxic effector T cell recruitment to inflamed tissues , 2003, Nature Immunology.

[18]  F. Sallusto,et al.  Functional subsets of memory T cells identified by CCR7 expression. , 2000, Current topics in microbiology and immunology.

[19]  T. Springer.  Traffic signals for lymphocyte recirculation and leukocyte emigration: The multistep paradigm , 1994, Cell.

[20]  Silvano Sozzani,et al.  The chemokine system in diverse forms of macrophage activation and polarization. , 2004, Trends in immunology.

[21]  M. Burdick,et al.  Critical Role for CXCR3 Chemokine Biology in the Pathogenesis of Bronchiolitis Obliterans Syndrome1 , 2002, The Journal of Immunology.

[22]  A. B. Kay,et al.  Allergy and Allergic Diseases , 2001 .

[23]  M. Schwarz,et al.  Multi-faceted strategies to combat disease by interference with the chemokine system. , 2005, Trends in immunology.

[24]  A. Rot.  Endothelial cell binding of NAP-1/IL-8: role in neutrophil emigration. , 1992, Immunology today.

[25]  Andrea Rosario Beccari,et al.  ELR+ CXC chemokines and their receptors (CXC chemokine receptor 1 and CXC chemokine receptor 2) as new therapeutic targets. , 2006, Pharmacology & therapeutics.

[26]  M. Cameron,et al.  The role of chemokines and chemokine receptors in alloantigen-independent and alloantigen-dependent transplantation injury. , 2003, Seminars in immunology.

[27]  C. Broder,et al.  CC CKR5: A RANTES, MIP-1α, MIP-1ॆ Receptor as a Fusion Cofactor for Macrophage-Tropic HIV-1 , 1996, Science.

[28]  M. Montjovent,et al.  Extension of Recombinant Human RANTES by the Retention of the Initiating Methionine Produces a Potent Antagonist (*) , 1996, The Journal of Biological Chemistry.

[29]  B. Rollins,et al.  Chemokines and disease , 2001, Nature Immunology.

[30]  P. Lusso,et al.  HIV and the chemokine system: 10 years later , 2006, The EMBO journal.

[31]  M. Cadene,et al.  Influence of Low Molecular Mass Heparin on the Kinetics of Neutrophil Elastase Inhibition by Mucus Proteinase Inhibitor(*) , 1995, The Journal of Biological Chemistry.

[32]  A. Mantovani,et al.  The chemokine system: redundancy for robust outputs. , 1999, Immunology today.

[33]  P. Libby,et al.  Differential Expression of the IFN-γ-Inducible CXCR3-Binding Chemokines, IFN-Inducible Protein 10, Monokine Induced by IFN, and IFN-Inducible T Cell α Chemoattractant in Human Cardiac Allografts: Association with Cardiac Allograft Vasculopathy and Acute Rejection1 , 2002, The Journal of Immunology.

[34]  Dianqing Wu,et al.  Roles of PLC-β2 and -β3 and PI3Kγ in Chemoattractant-Mediated Signal Transduction , 2000 .

[35]  A. Luster,et al.  Chemokines--chemotactic cytokines that mediate inflammation. , 1998, The New England journal of medicine.

[36]  J. Chute.  Stem cell homing , 2006, Current opinion in hematology.

[37]  D. F. Barber,et al.  PI3Kγ inhibition blocks glomerulonephritis and extends lifespan in a mouse model of systemic lupus , 2005, Nature Medicine.

[38]  A B Kay,et al.  Allergy and allergic diseases. First of two parts. , 2001, The New England journal of medicine.

[39]  U. V. von Andrian,et al.  CXCL12 Mediates CCR7-independent Homing of Central Memory Cells, But Not Naive T Cells, in Peripheral Lymph Nodes , 2004, The Journal of experimental medicine.

[40]  I. Charo,et al.  Decreased lesion formation in CCR2−/− mice reveals a role for chemokines in the initiation of atherosclerosis , 1998, Nature.

[41]  T. Cupedo,et al.  Role of chemokines in the development of secondary and tertiary lymphoid tissues. , 2003, Seminars in immunology.

[42]  M. Lederman,et al.  Prevention of Vaginal SHIV Transmission in Rhesus Macaques Through Inhibition of CCR5 , 2004, Science.

[43]  H. Auchincloss,et al.  The role of CC chemokine receptor 5 (CCR5) in islet allograft rejection. , 2002, Diabetes.

[44]  J J Goedert,et al.  Genetic Restriction of HIV-1 Infection and Progression to AIDS by a Deletion Allele of the CKR5 Structural Gene , 1996, Science.

[45]  S. O. Smith,et al.  A binding pocket for a small molecule inhibitor of HIV-1 entry within the transmembrane helices of CCR5. , 2000, Proceedings of the National Academy of Sciences of the United States of America.

[46]  R. Doms,et al.  Use of a Small Molecule CCR5 Inhibitor in Macaques to Treat Simian Immunodeficiency Virus Infection or Prevent Simian–Human Immunodeficiency Virus Infection , 2003, The Journal of experimental medicine.

[47]  K. Matsushima,et al.  Essential involvement of interleukin‐8 (IL‐8) in acute inflammation , 1994, Journal of leukocyte biology.

[48]  Joseph Sodroski,et al.  CD4-induced interaction of primary HIV-1 gp120 glycoproteins with the chemokine receptor CCR-5 , 1996, Nature.

[49]  W. Hancock,et al.  Requirement of the Chemokine Receptor CXCR3 for Acute Allograft Rejection , 2000, The Journal of experimental medicine.

[50]  Edward J. Fuchs,et al.  Pharmacokinetics and Safety of AMD-3100, a Novel Antagonist of the CXCR-4 Chemokine Receptor, in Human Volunteers , 2000, Antimicrobial Agents and Chemotherapy.

[51]  Richard A Koup,et al.  Homozygous Defect in HIV-1 Coreceptor Accounts for Resistance of Some Multiply-Exposed Individuals to HIV-1 Infection , 1996, Cell.

[52]  L. Mayer,et al.  Colonic epithelial cells are a major site of macrophage inflammatory protein 3α (MIP-3α) production in normal colon and inflammatory bowel disease , 2002, Gut.

[53]  W L Stanford,et al.  Function of PI3Kgamma in thymocyte development, T cell activation, and neutrophil migration. , 2000, Science.

[54]  J. Gong,et al.  An Antagonist of Monocyte Chemoattractant Protein 1 (MCP-1) Inhibits Arthritis in the MRL-lpr Mouse Model , 1997, The Journal of experimental medicine.

[55]  Subrata Ghosh,et al.  Natalizumab for active Crohn's disease. , 2003, The New England journal of medicine.

[56]  Antonio Lanzavecchia,et al.  Regulation of Dendritic Cell Migration to the Draining Lymph Node , 2003, The Journal of experimental medicine.

[57]  W. Glass,et al.  Antibody Targeting of the CC Chemokine Ligand 5 Results in Diminished Leukocyte Infiltration into the Central Nervous System and Reduced Neurologic Disease in a Viral Model of Multiple Sclerosis1 , 2004, The Journal of Immunology.

[58]  A. Zlotnik,et al.  The chemokine and chemokine receptor superfamilies and their molecular evolution , 2006, Genome Biology.

[59]  Jinquan Tan,et al.  Chemokine receptors and transplantation. , 2005, Cellular & molecular immunology.

[60]  A. Tager,et al.  T-cell trafficking in asthma: lipid mediators grease the way , 2004, Nature Reviews Immunology.

[61]  H. Bourne,et al.  Pertussis toxin inhibition of chemotactic factor-induced calcium mobilization and function in human polymorphonuclear leukocytes , 1985, The Journal of experimental medicine.

[62]  S. Bromley,et al.  Chemokine receptor CCR7 guides T cell exit from peripheral tissues and entry into afferent lymphatics , 2005, Nature Immunology.

[63]  C. Martínez-A,et al.  Chemokine signaling and functional responses: the role of receptor dimerization and TK pathway activation. , 2001, Annual review of immunology.

[64]  F. Luscinskas,et al.  Fractalkine Preferentially Mediates Arrest and Migration of CD16+ Monocytes , 2003, The Journal of experimental medicine.

[65]  M. Tabrizi,et al.  Efficacy and safety of a monoclonal antibody recognizing interleukin-8 in COPD: a pilot study. , 2004, Chest.

[66]  P. Hjelmström.  Lymphoid neogenesis: de novo formation of lymphoid tissue in chronic inflammation through expression of homing chemokines , 2001, Journal of leukocyte biology.

[67]  T. Handel,et al.  Interaction of chemokines and glycosaminoglycans: a new twist in the regulation of chemokine function with opportunities for therapeutic intervention. , 2005, Cytokine & growth factor reviews.

[68]  John P. Moore,et al.  Protection of macaques from vaginal SHIV challenge by an orally delivered CCR5 inhibitor , 2005, Nature Medicine.

[69]  T. Schwartz,et al.  Potent inhibition of HIV-1 infectivity in macrophages and lymphocytes by a novel CCR5 antagonist. , 1997, Science.

[70]  M. Sho,et al.  A Novel Small-Molecule Compound Targeting CCR5 and CXCR3 Prevents Acute and Chronic Allograft Rejection , 2005, Transplantation.

[71]  M. Miyasaka,et al.  Lymphocyte trafficking across high endothelial venules: dogmas and enigmas , 2004, Nature Reviews Immunology.

[72]  M. Baggiolini,et al.  Binding to heparan sulfate or heparin enhances neutrophil responses to interleukin 8. , 1993, Proceedings of the National Academy of Sciences of the United States of America.

[73]  D. Dimitrov,et al.  Evidence for Cell-Surface Association Between Fusin and the CD4-gp120 Complex in Human Cell Lines , 1996, Science.

[74]  R. Geha,et al.  CCR3 is essential for skin eosinophilia and airway hyperresponsiveness in a murine model of allergic skin inflammation. , 2002, The Journal of clinical investigation.

[75]  A. Morgan,et al.  Differential expression of CCR3 and CXCR3 by human lung and bone marrow‐derived mast cells: implications for tissue mast cell migration , 2005, Journal of leukocyte biology.

[76]  B. Medoff,et al.  Multiple Chemokine Receptors, Including CCR6 and CXCR3, Regulate Antigen-Induced T Cell Homing to the Human Asthmatic Airway1 , 2007, The Journal of Immunology.

[77]  H. Auchincloss,et al.  Differential Role of CCR2 in Islet and Heart Allograft Rejection: Tissue Specificity of Chemokine/Chemokine Receptor Function In Vivo1 , 2004, The Journal of Immunology.

[78]  Virginia Litwin,et al.  HIV-1 entry into CD4+ cells is mediated by the chemokine receptor CC-CKR-5 , 1996, Nature.

[79]  T. Ahmed,et al.  Inhibition of allergic late airway responses by inhaled heparin-derived oligosaccharides. , 2000, Journal of applied physiology.

[80]  C. Geula,et al.  Ccr2 deficiency impairs microglial accumulation and accelerates progression of Alzheimer-like disease , 2007, Nature Medicine.

[81]  R. Gerszten,et al.  Leukotriene B4 receptor BLT1 mediates early effector T cell recruitment , 2003, Nature Immunology.

[82]  Emilio Hirsch,et al.  Blockade of PI3Kγ suppresses joint inflammation and damage in mouse models of rheumatoid arthritis , 2005, Nature Medicine.

[83]  Marc Parmentier,et al.  Resistance to HIV-1 infection in Caucasian individuals bearing mutant alleles of the CCR-5 chemokine receptor gene , 1996, Nature.

[84]  K. Matsushima,et al.  Prevention of lung reperfusion injury in rabbits by a monoclonal antibody against interleukin-8 , 1993, Nature.

[85]  B. Medoff,et al.  Cutting Edge: Th2 Cell Trafficking into the Allergic Lung Is Dependent on Chemoattractant Receptor Signaling1 , 2002, The Journal of Immunology.

[86]  M. Mack,et al.  Interference with Heparin Binding and Oligomerization Creates a Novel Anti-Inflammatory Strategy Targeting the Chemokine System , 2004, The Journal of Immunology.

[87]  L. Picker,et al.  Lymphocyte Homing and Homeostasis , 1996, Science.

[88]  E. Kunkel,et al.  Rules of chemokine receptor association with T cell polarization in vivo. , 2001, The Journal of clinical investigation.

[89]  F. Finkelman,et al.  Interleukin‐4‐ and interleukin‐13‐mediated host protection against intestinal nematode parasites , 2004, Immunological reviews.

[90]  D. Schols.  HIV co-receptor inhibitors as novel class of anti-HIV drugs. , 2006, Antiviral research.

[91]  E. Clercq.  The bicyclam AMD3100 story , 2003, Nature Reviews Drug Discovery.

[92]  E. Wolf,et al.  CCR7 Coordinates the Primary Immune Response by Establishing Functional Microenvironments in Secondary Lymphoid Organs , 1999, Cell.

[93]  Pietro Ghezzi,et al.  Noncompetitive allosteric inhibitors of the inflammatory chemokine receptors CXCR1 and CXCR2: prevention of reperfusion injury. , 2004, Proceedings of the National Academy of Sciences of the United States of America.

[94]  R. Weissleder,et al.  Oligomerization of CXCL10 Is Necessary for Endothelial Cell Presentation and In Vivo Activity1 , 2006, The Journal of Immunology.

[95]  Ulrich H. von Andrian,et al.  Homing and cellular traffic in lymph nodes , 2003, Nature Reviews Immunology.

[96]  Stefan Fischer,et al.  Interleukin-8 release during early reperfusion predicts graft function in human lung transplantation. , 2002, American journal of respiratory and critical care medicine.

[97]  Albert Zlotnik.  Chemokines and cancer , 2006, International journal of cancer.

[98]  William C. Olson,et al.  CD4-dependent, antibody-sensitive interactions between HIV-1 and its co-receptor CCR-5 , 1996, Nature.

[99]  K. Matsushima,et al.  International union of pharmacology. XXII. Nomenclature for chemokine receptors. , 2000, Pharmacological reviews.

[100]  V. Kuchroo,et al.  TH-17 cells in the circle of immunity and autoimmunity , 2007, Nature Immunology.

[101]  P. Sterk,et al.  Effect of inhaled heparin on allergen-induced early and late asthmatic responses in patients with atopic asthma. , 1996, American journal of respiratory and critical care medicine.

[102]  H. Greenberg,et al.  CCR6 mediates dendritic cell localization, lymphocyte homeostasis, and immune responses in mucosal tissue. , 2000, Immunity.

[103]  R. Ransohoff,et al.  The many roles of chemokines and chemokine receptors in inflammation. , 2006, The New England journal of medicine.

[104]  L. Lindbom,et al.  Leukocyte and endothelial cell adhesion molecules as targets for therapeutic interventions in inflammatory disease. , 2003, Trends in pharmacological sciences.

[105]  J. Cyster,et al.  Chemokines, sphingosine-1-phosphate, and cell migration in secondary lymphoid organs. , 2005, Annual review of immunology.

[106]  Alberto Mantovani,et al.  Tuning inflammation and immunity by chemokine sequestration: decoys and more , 2006, Nature Reviews Immunology.

[107]  H. Weiner,et al.  Resistance to Experimental Autoimmune Encephalomyelitis in Mice Lacking the Cc Chemokine Receptor (Ccr2) , 2000, The Journal of experimental medicine.

[108]  D. Kaufman,et al.  Genetic deletion of chemokine receptor CXCR3 or antibody blockade of its ligand IP-10 modulates posttransplantation graft-site lymphocytic infiltrates and prolongs functional graft survival in pancreatic islet allograft recipients. , 2003, Surgery.

[109]  A. Viola,et al.  T cells and their partners: The chemokine dating agency. , 2006, Trends in immunology.

[110]  Timothy J. Williams,et al.  Site-directed Mutagenesis of CC Chemokine Receptor 1 Reveals the Mechanism of Action of UCB 35625, a Small Molecule Chemokine Receptor Antagonist* , 2005, Journal of Biological Chemistry.

[111]  B. Zheng,et al.  CXCL13 neutralization reduces the severity of collagen-induced arthritis. , 2005, Arthritis and rheumatism.

[112]  David H. Miller,et al.  A controlled trial of natalizumab for relapsing multiple sclerosis. , 2003, The New England journal of medicine.

[113]  M. Burdick,et al.  CXC chemokines in angiogenesis , 2000, Journal of leukocyte biology.

[114]  N. Kaneider,et al.  Reversing systemic inflammatory response syndrome with chemokine receptor pepducins , 2005, Nature Medicine.

[115]  James J. Campbell,et al.  CC Chemokine Receptor (CCR)4 and the CCR10 Ligand Cutaneous T Cell–attracting Chemokine (CTACK) in Lymphocyte Trafficking to Inflamed Skin , 2001, The Journal of experimental medicine.

[116]  Stephen C. Peiper,et al.  Identification of a major co-receptor for primary isolates of HIV-1 , 1996, Nature.

[117]  P. Bongrand,et al.  Upregulation of chemokines in bronchoalveolar lavage fluid as a predictive marker of post-transplant airway obliteration. , 2002, The Journal of heart and lung transplantation : the official publication of the International Society for Heart Transplantation.

[118]  Steffen Jung,et al.  Blood monocytes consist of two principal subsets with distinct migratory properties. , 2003, Immunity.

[119]  S. Bowler,et al.  Heparin inhibits the immediate response to antigen in the skin and lungs of allergic subjects. , 1993, The American review of respiratory disease.

[120]  S. Hwang,et al.  Chemokines, chemokine receptors, and cancer metastasis , 2006, Journal of leukocyte biology.

[121]  A. Krensky,et al.  Chemokines, chemokine receptors, and allograft rejection. , 2001, Immunity.